Brainsway‘s transcranial magnetic stimulation (TMS) technology is finding itself useful in ever more clinical applications as the European Union just issued the CE Mark for the company’s Deep TMS system to be used for treatment of neuropathic chronic pain.
The technology delivers targeted magnetic pulses deep into the brain, inducing electrical signals that can activate neurons in the localized region, which seems to help for a number of disorders. The System already has the CE Mark indicating its use for clinical depression, bi-polar disorder, schizophrenia (negative symptoms), Parkinson’s diseases and post-traumatic stress disorder.
Press release: Brainsway Receives CE Mark Approval for Its Deep TMS System to Treat Neuropathic Chronic Pain…
Brainsway’s transcranial magnetic stimulation info page…
Medgadget‘s previous Brainsway coverage: Brainsway’s Transcranial Magnetic Stimulation to Go on Trial for Bipolar Disorder; Transcranial Magnetic Stimulation Shows Initial Promise in Alzheimer’s Trial; Brainsway’s Transcranial Magnetic Stimulation Gets European Regulatory Approval for Treatment of Depression; Brainsway to Test TMS for Smoking Cessation; Positive Results Reported for Deep TMS H System For Depression; Deep TMS Technology by Brainsway; VA to Trial Transcranial Magnetic Stimulation for ADD